Brain tumor drug study halted before it even started
NCT ID NCT06012929
First seen Jan 27, 2026 · Last updated May 24, 2026 · Updated 14 times
Summary
This study was designed to test the drug ONC201 in people with a type of brain tumor called meningioma that had come back or wasn't responding to other treatments. The plan was to measure how much drug gets into the tumor during surgery and how long it keeps the tumor from growing. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGIOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.